Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastases
Interventions: DRUG: vinflunine|DRUG: Alkylating agent of physician choice registered in cancer
Sponsor: Pierre Fabre Medicament